Immatics IMTX
NASDAQ IMTX
$9.56 +0.10 (+1.06%)
As of: Sep 4, 2026 · 3:59 PM EDT

Immatics (IMTX) Change in Account Payables (2020 - 2022)

Immatics (IMTX) posted Change in Account Payables of $69.7 million for Q2 2022, up 89.22% sequentially from $36.8 million in Q1 2022, and up 1325.95% YoY from $4.9 million in Q2 2021.

Analysis

Immatics (IMTX) Change in Account Payables (2020 - 2022) Analysis & Trends

Immatics has reported Change in Account Payables for 3 years, with the latest figure at $69.7 million in Q2 2022.

  • Quarterly Change in Account Payables rose 1325.95% year-over-year to $69.7 million in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $83.0 million (up 377.8% YoY) and the FY2021 annual result came in at -$37.6 million, down 40.86% from the prior year.
  • Change in Account Payables advanced to $69.7 million in Q2 2022 per IMTX's latest filing, from $36.8 million in the prior quarter.
  • Over five years, Change in Account Payables peaked at $69.7 million in Q2 2022 and troughed at -$20.1 million in Q4 2021.
  • A 3-year average of $4.2 million and a median of -$5.4 million in 2020 frame the typical range for Change in Account Payables.
  • The sharpest annual moves came in 2021 and 2022: Change in Account Payables plunged 82.9% in 2021, then jumped 1325.95% in 2022.
  • Over 3 years, Change in Account Payables stood at -$11.0 million in 2020, then slumped by 82.9% to -$20.1 million in 2021, then soared by 446.93% to $69.7 million in 2022.
  • According to Business Quant data, Change in Account Payables over the past three periods registered $69.7 million, $36.8 million, and -$20.1 million for Q2 2022, Q1 2022, and Q4 2021 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -66.70 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -8.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 5.03 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 37.53 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Immatics 1.17 Bn 711.21 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 69.66 Mn
Mar 31, 2022 36.81 Mn
Dec 31, 2021 -20.08 Mn
Sep 30, 2021 -3.38 Mn
Jun 30, 2021 -5.68 Mn
Mar 31, 2021 -8.02 Mn
Dec 31, 2020 -10.98 Mn
Sep 30, 2020 -5.20 Mn
Jun 30, 2020 -6.32 Mn
Mar 31, 2020 -4.40 Mn